Stelara 90 MG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26FFLP0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,584
Award facts
- Contract value 100% obligated
- $16,584.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $16,584.13 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on January 8, 2026, for the supply of Stelara 90 mg/ml syringes with an ultimate completion date of January 30, 2026. This delivery order was issued without set-aside designation, leveraging DMS Pharmaceutical Group's competitive capabilities in unrestricted federal procurement. The award is executed under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy with a $499.9 billion ceiling authorized through December 31, 2036.
DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, specializing in the distribution of branded and generic prescription medications, biologics, vaccines, and medical consumables to federal agencies, particularly the Department of Defense. The company has demonstrated substantial performance across multiple delivery orders since its PPV-G GEN V contract award on November 13, 2025, supplying critical pharmaceutical products to support military healthcare operations globally. As a prime contractor with no identified subcontractors on this award, DMS Pharmaceutical Group serves as a key regional vendor within DLA's Medical Supply Chain division, fulfilling the diverse and specialized pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FFLP0?
SPE2DR26FFLP0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26FFLP0 worth?
The government has obligated $16,584 on SPE2DR26FFLP0.
Is contract SPE2DR26FFLP0 an order under another contract?
Yes. SPE2DR26FFLP0 is a delivery order under SPE2DR25D9227, an indefinite delivery contract.
Was contract SPE2DR26FFLP0 competed?
The extent of competition for SPE2DR26FFLP0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award